Assessment of Strength, Balance, and Function in Above-Knee Amputees in Relation to Residual Limb Length
NCT ID: NCT07032233
Last Updated: 2025-06-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
15 participants
OBSERVATIONAL
2025-06-30
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
How does the length of the lost part of the leg, compared to the intact leg, affect muscle strength, balance, and functional capacity?
Is muscle strength at specific lower limb joints related to balance and performance ?
Participants will:
Have muscle strength measured at all intact lower limb joints using an isokinetic dynamometer
Complete balance assessments using force platform technology that measures weight distribution and evaluates both static and dynamic balance
Perform a six-minute walk test to evaluate endurance and functional capacity
The study will help improve understanding of how limb length and joint-specific muscle strength impact mobility, supporting the development of better rehabilitation programs for amputees.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Dual Task Balance Training In Individuals With Above Knee Amputation
NCT03094208
The Relationship Between Thicknesses and Isokinetic Strength of Hip Flexor and Extensor Muscles
NCT05827744
Rectus Femoris Thickness Measurement in Unilateral Transtibial Amputated Prosthesis Users
NCT04262297
Anthropometric Predictability of Full-Thickness Peroneus Longus and Semitendinosus Autograft Size
NCT06769724
Increased Femoral Anteversion and Physical Performance
NCT05882981
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
transfemoral amputation
Adults with unilateral transfemoral amputation who indepently ambulates with a prosthetic limb.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Are between 18 and 50 years of age
Are literate
Have unilateral transfemoral amputation
Have no cardiovascular, orthopedic, cognitive, or neurological conditions that could negatively affect balance, gait, or muscle strength
Are able to ambulate independently with a prosthesis
Have been walking for at least 6 months
Voluntarily agree to participate in the study
Exclusion Criteria
They develop complications such as pain (rated 3 or higher on the Visual Analog Scale) or stump irritation during the course of the study
Their residual limb length is less than 25 cm from the greater trochanter, which exceeds the limitations of the isokinetic dynamometer attachments used in the study
They voluntarily withdraw from the study - in such cases, their data will be removed from the records
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
OTHER
Hacettepe University
OTHER
Ceren Kuzu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ceren Kuzu
PhD Candidate, Physiotherapist
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FTREK25/31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.